HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nociception in persistent pancreatitis in rats: effects of morphine and neuropeptide alterations.

AbstractBACKGROUND:
Most animal models of pancreatitis are short-lived or very invasive. A noninvasive animal model of pancreatitis developed in highly inbred rats by Merkord with symptoms persisting for 3 weeks was adopted in the current study to test its validity as a model of visceral pain in commercially available rats.
METHODS:
The persistent pancreatitis model was established by tail vein injection of dibutyltin dichloride. Animals were given 10% alcohol in their drinking water to enhance the pancreatitis attack. Blood serum pancreatic enzymes and nociceptive state were monitored for 3 weeks after dibutyltin dichloride or vehicle. Behavioral testing included reflexive withdrawal to mechanical and thermal stimulation of the abdominal area. The effect of morphine on nociceptive behaviors was tested. Histologic analysis of the pancreas and immunohistochemical analysis of substance P and calcitonin gene-related peptide in the spinal cord are included in the study.
RESULTS:
Compared with naïve and vehicle-only injected control groups, rats receiving dibutyltin dichloride demonstrated an increase in withdrawal events after von Frey stimulation and decreased withdrawal latency after thermal stimulation, signaling a sensitized nociceptive state through 7 days. These pain-related measures were abrogated by morphine. Blood serum concentrations of amylase and lipase as well as tissue inflammatory changes and substance P were also significantly elevated during this same time period.
CONCLUSIONS:
These results indicate that animals with the dibutyltin dichloride-induced experimental pancreatitis expressed serum, histologic, and behavioral characteristics similar in duration to those present during acute attacks experienced by patients with chronic pancreatitis. These findings and responsivity to morphine suggest the utility of this model developed in a commercially available strain of rats for study of persistent visceral pain.
AuthorsLouis P Vera-Portocarrero, Ying Lu, Karin N Westlund
JournalAnesthesiology (Anesthesiology) Vol. 98 Issue 2 Pg. 474-84 (Feb 2003) ISSN: 0003-3022 [Print] United States
PMID12552208 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Analgesics, Opioid
  • Neuropeptides
  • Organotin Compounds
  • di-n-butyltin
  • Substance P
  • Morphine
  • Lipase
  • Amylases
  • Calcitonin Gene-Related Peptide
Topics
  • Amylases (blood)
  • Analgesics, Opioid (therapeutic use)
  • Animals
  • Behavior, Animal (drug effects)
  • Calcitonin Gene-Related Peptide (metabolism)
  • Chronic Disease
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Hyperalgesia (drug therapy, psychology)
  • Immunohistochemistry
  • Lipase (blood)
  • Male
  • Morphine (therapeutic use)
  • Neuropeptides (metabolism)
  • Organotin Compounds (toxicity)
  • Pain (etiology, metabolism, psychology)
  • Pain Measurement (drug effects)
  • Pancreas (pathology)
  • Pancreatitis (chemically induced, complications, pathology)
  • Physical Stimulation
  • Rats
  • Rats, Inbred Lew
  • Substance P (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: